Exonate

Developer of small molecule drugs for retinal vascular diseases

placeNottingham, England, United Kingdom calendar_todayFounded 2013 groups17 employees language exonate.com

Registered entities

Innovation

8 patent families (5 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 361 times.

YearFilings
20151
20172
20183
20194
20205
20213
20223
20232
20241
20252

Social engagement

Social engagement: 1.3K social following, 2 posts in the last 12 months — top 10% of its industry.

Investor mix

48 investors on record; lead investors include Wren Capital, Uniseed, Parkwalk, Martlet Capital.

Investor typeCountShare
Venture capital817%
Angel & family office12%
Bank & private debt12%
Other / undisclosed3879%

Recent activity

27 Nov 2025
Recognition
Coming soon